Calcinosis in a Single-Center Scleroderma Population
| Status: | Recruiting |
|---|---|
| Conditions: | Skin and Soft Tissue Infections, Dermatology, Dermatology, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 2/14/2018 |
| Start Date: | October 2012 |
| End Date: | December 2030 |
| Contact: | Vivien Hsu, MD |
| Email: | hsuvm@rwjms.rutgers.edu |
| Phone: | 732-418-8484 |
A Prospective, Observational Study of Calcinosis in a Single-Center Population With Scleroderma-Spectrum Disorders
This is a 10 year study of scleroderma patients with calcinosis 1) to better understand how
common and if there are any risk factors for having calcinosis
2) to identify common complications associated with scleroderma-related calcinosis.
common and if there are any risk factors for having calcinosis
2) to identify common complications associated with scleroderma-related calcinosis.
This is a prospective study of scleroderma- spectrum patients focused on soft tissue
calcinosis in order 1) to better understand the risk factors (including clinical/laboratory
characteristics, and serology) of calcinosis in the scleroderma-spectrum disorders (limited
or diffuse systemic sclerosis with or without overlap of inflammatory arthritis and/or
myositis).
2) view common complications associated with calcinosis.
Better understanding of scleroderma calcinosis would lead to other studies that eventually
will define better treatment options for this incurable and often disabling complication.
calcinosis in order 1) to better understand the risk factors (including clinical/laboratory
characteristics, and serology) of calcinosis in the scleroderma-spectrum disorders (limited
or diffuse systemic sclerosis with or without overlap of inflammatory arthritis and/or
myositis).
2) view common complications associated with calcinosis.
Better understanding of scleroderma calcinosis would lead to other studies that eventually
will define better treatment options for this incurable and often disabling complication.
Inclusion Criteria:
- Adult scleroderma subjects with and without calcinosis
Exclusion Criteria:
- Subjects unwilling to participate
We found this trial at
1
site
Click here to add this to my saved trials
